Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Di Bello

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Virology|September 1, 1991
Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanismA De Rossi, M Pasti, F Mammano, et al.
FEBS Letters|February 13, 1984
C-terminal amidation of neuropeptides. Gly-Lys-Arg extension an efficient precursor of C-terminal amideS Gomez, C di Bello, T H Lam, et al.
Biochemical and Biophysical Research Communications|August 2, 2003
CCR5 N-terminus peptides enhance X4 HIV-1 infection by CXCR4 up-regulationM Dettin, M Zanchetta, A Pasquato, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 10, 2001
A type-II beta-turn, proline-containing, cyclic pentapeptide as a building block for the construction of models of the cleavage site of pro-oxytocinM Dettin, L Falcigno, T Campanile, et al.
Human Immunology|June 11, 1999
Definition of the alpha 2 region of HLA-DR molecules involved in CD4 bindingM Gaubin, R Houlgatte, M Dettin, et al.
Virology|February 1, 1995
Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infectionC Zanotto, F Calderazzo, M Dettin, et al.
Leukemia|October 24, 2003
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapyM Coscia, S Mariani, S Battaglio, et al.
Biopolymers|October 15, 1991
Conformational studies on bombesin antagonists: CD and NMR characterization of [Thr6, Leu13 psi(CH2NH) Met14] bombesin (6-14)C Di Bello, A Scatturin, G Vertuani, et al.
Biochemical and Biophysical Research Communications|June 30, 1989
Conformation studies on bombesin receptor antagonists: 500 MHz NMR and CD characterization of synthetic (D-Phe12, Leu14)-bombesinC Di Bello, A Scanelli, M G Corradini, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 1, 1995
Conformational studies on synthetic peptides reproducing the dibasic processing site of pro-ocytocin-neurophysinC Di Bello, M Simonetti, M Dettin, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Virology|September 1, 1991
Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanismA De Rossi, M Pasti, F Mammano, et al.
FEBS Letters|February 13, 1984
C-terminal amidation of neuropeptides. Gly-Lys-Arg extension an efficient precursor of C-terminal amideS Gomez, C di Bello, T H Lam, et al.
Biochemical and Biophysical Research Communications|August 2, 2003
CCR5 N-terminus peptides enhance X4 HIV-1 infection by CXCR4 up-regulationM Dettin, M Zanchetta, A Pasquato, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 10, 2001
A type-II beta-turn, proline-containing, cyclic pentapeptide as a building block for the construction of models of the cleavage site of pro-oxytocinM Dettin, L Falcigno, T Campanile, et al.
Human Immunology|June 11, 1999
Definition of the alpha 2 region of HLA-DR molecules involved in CD4 bindingM Gaubin, R Houlgatte, M Dettin, et al.
Virology|February 1, 1995
Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infectionC Zanotto, F Calderazzo, M Dettin, et al.
Leukemia|October 24, 2003
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapyM Coscia, S Mariani, S Battaglio, et al.
Biopolymers|October 15, 1991
Conformational studies on bombesin antagonists: CD and NMR characterization of [Thr6, Leu13 psi(CH2NH) Met14] bombesin (6-14)C Di Bello, A Scatturin, G Vertuani, et al.
Biochemical and Biophysical Research Communications|June 30, 1989
Conformation studies on bombesin receptor antagonists: 500 MHz NMR and CD characterization of synthetic (D-Phe12, Leu14)-bombesinC Di Bello, A Scanelli, M G Corradini, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 1, 1995
Conformational studies on synthetic peptides reproducing the dibasic processing site of pro-ocytocin-neurophysinC Di Bello, M Simonetti, M Dettin, et al.
Pageof 6